The stock of CTI BioPharma Corp (CTIC) closed the regular trading session at $3.95, gaining 17.21% from the previous day’s trading session. On the last
CTI BioPharma Corp. (CTIC) a commercial-stage biotherapeutics company engaged in the purchase, manufacture, and marketing of innovative targeted therapeutics for blood cancer. The company’s one
CTI BioPharma Corp. (CTIC) stock prices stayed stable over the course of the trading day on June 25th, 2021. After-hours trading saw the stock climb
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.